Medicare Aranesp Reimbursement Drops “Equitable Adjustment” To Procrit

Medicare will no longer consider Amgen's Aranesp to be "functionally equivalent" to Johnson & Johnson's Procrit when reimbursing hospitals for outpatient use of the biological product